Asarfi Hospital Ltd543943Corporate

Latest results: Jun 2026 10 quarters of data

—

MCap —

Live price not available

Asarfi Hospital Ltd — Stock analysis & AI research Asarfi Hospital Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹47 Cr

Sales · Jun 2026

+32.8% YoY

₹9 Cr

Operating Profit · Jun 2026

+34.0% YoY

19.9%

OPM % · Jun 2026

+1.0% YoY

₹4 Cr

Net Profit · Jun 2026

+33.4% YoY

₹2.17

EPS · Jun 2026

+33.1% YoY

📝 Asarfi Hospital Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Asarfi Hospital Ltd reported revenue of ₹47 crore for the quarter ended June 2026 (Q1 FY27), up 32.8% from ₹36 crore in the same quarter last year, and up 5.1% sequentially over the March 2026 quarter.

Net profit rose 33.4% year-on-year to ₹4 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹2.17.

Operating profit stood at ₹9 crore — an operating margin (OPM) of 19.9%, compared with 19.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Asarfi Hospital Ltd posted revenue of ₹172 crore, a growth of 73.6% over FY25, with a net profit of ₹17 crore (up 80.6% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹183 crore with a net profit of ₹18 crore.

Shareholding pattern

As of Jun 2026, promoters held 61.17%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 2.97%, public shareholders 35.87% of Asarfi Hospital Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹183 Cr

OPM ?

19.8%

Profit after tax (TTM) ?

₹18 Cr

EPS (TTM) ?

₹9.22

ROCE ?

19.0%

ROE ?

18.3%

ROA ?

9.3%

Growth

Sales — latest qtr ?

₹47 Cr

PAT — latest qtr ?

₹4 Cr

YoY qtr sales growth ?

32.8%

YoY qtr profit growth ?

33.4%

Sales growth (3y) ?

36%

Sales growth (5y) ?

26%

Profit growth (3y) ?

29%

Profit growth (5y) ?

37%

Financial Health

Debt ?

₹58 Cr

Debt to Equity ?

0.59

Interest Coverage ?

5.3

Current Ratio ?

N/A

Ownership

Promoter holding ?

61.17%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (10 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	20	24	31	33	35	36	45	46	45	47	+32.8%	+5.1%
Operating Profit	4	4	7	7	6	7	9	10	8	9	+34.0%	+19.8%
Other Income	1	-0	1	1	4	1	1	2	1	1	-58.3%	-11.6%
Interest	1	1	1	1	1	1	1	1	1	1	-4.2%	+64.7%
Depreciation	3	3	3	3	3	3	3	3	3	3	+5.9%	+14.4%
Profit Before Tax	1	-1	4	4	6	4	6	8	5	6	+33.7%	+12.4%
Net Profit	-0	-0	3	3	4	3	4	5	4	4	+33.4%	+4.4%
EPS	-0.03	-0.08	1.47	1.38	1.95	1.63	2.19	2.78	2.08	2.17	+33.1%	+4.3%
OPM %	20.0%	16.6%	22.0%	21.3%	18.4%	19.7%	19.9%	21.9%	17.5%	19.9%	+1.0%	+13.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹99 Cr	₹172 Cr	₹183 Cr	+73.6%
Operating Profit	₹20 Cr	₹34 Cr	₹36 Cr	+67.5%
OPM %	20.49%	19.76%	19.80%	-3.6%
NPM %	9.56%	9.95%	9.90%	+4.1%
Other Income	₹6 Cr	₹4 Cr	₹4 Cr	-22.7%
Depreciation	₹9 Cr	₹11 Cr	₹12 Cr	+21.1%
Interest	₹3 Cr	₹4 Cr	₹4 Cr	+29.2%
EBIT	₹11 Cr	₹22 Cr	₹25 Cr	+108.1%
PBT	₹13 Cr	₹23 Cr	₹24 Cr	+71.4%
Tax	—	—	₹1 Cr	—
Net Profit	₹9 Cr	₹17 Cr	₹18 Cr	+80.6%
EPS	₹4.80	₹8.68	₹9.22	+80.8%
Material Cost	—	—	₹11 Cr	—
Employee Cost	—	—	₹8 Cr	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	14	20	20	20	+0.0%
Reserves	27	51	62	79	+27.4%
Borrowings	17	32	49	58	+18.4%
Other Liabilities	34	52	34	38	+11.8%
Total Liabilities	93	154	164	194	+18.3%
Fixed Assets	39	94	101	108	+6.9%
CWIP	18	0	2	2	+0.0%
Investments	0	0	0	0	—
Other Assets	37	60	61	84	+37.7%
Total Assets	93	154	164	194	+18.3%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	7	26	-4	19	+575.0%
Cash from Investing Activity	-21	-63	-8	-19	-137.5%
Cash from Financing Activity	15	36	13	5	-61.5%
Net Cash Flow	1	-1	1	5	+400.0%
Free Cash Flow	-13	-20	-14	1	+107.1%
CFO/OP	73%	162%	-3%	69%	+2400.0%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	90	109	125	114	-8.8%
Inventory Days	26	32	30	30	+0.0%
Days Payable	91	445	171	156	-8.8%
Cash Conversion Cycle	25	-304	-16	-12	+25.0%
Working Capital Days	18	3	50	19	-62.0%
ROCE %	26%	11%	16%	19%	+18.8%

👥 Shareholding (latest 4 periods)

Metric	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	61.17%	61.17%	61.17%	61.17%	+0.0%
FIIs	0.05%	0.00%	0.00%	0.00%	—
DIIs	2.18%	1.98%	2.40%	2.97%	+23.8%
Public	36.59%	36.86%	36.44%	35.87%	-1.6%
No. of Shareholders	1,167	1,225	1,316	1,399	+6.3%

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was Asarfi Hospital Ltd's revenue in Q1 FY27?

What was Asarfi Hospital Ltd's net profit in Q1 FY27?